BMY Stock Recent News

BMY LATEST HEADLINES

BMY Stock News Image - Reuters

Bristol Myers Squibb aims to expand its research and development presence in India and expects its newly inaugurated Hyderabad facility to become its largest unit outside the U.S. by 2025, CEO Christopher Boerner said on Tuesday.

Reuters 2024 Feb 27
BMY Stock News Image - Zacks Investment Research

BXMT, BMY and CWEN have been added to the Zacks Rank #5 (Strong Sell) List on February 26, 2023.

Zacks Investment Research 2024 Feb 26
BMY Stock News Image - Zacks Investment Research

Bristol Myers (BMY) announces FDA's acceptance of the sNDA seeking approval for the Krazati/Erbitux combo therapy to treat CRC patients. A final decision is expected on Jun 21, 2024.

Zacks Investment Research 2024 Feb 21
BMY Stock News Image - Forbes

Bristol Myers Squibb BMY (NYSE: BMY) reported its Q4 results earlier this month, with revenues and earnings beating the street estimates. The company reported revenue of $11.5 billion and adjusted earnings of $1.70 per share compared to the consensus estimates of $11.2 billion in sales and $1.53 profit per share.

Forbes 2024 Feb 21
BMY Stock News Image - InvestorPlace

Picking the best stocks for beginning investors is crucial as they enter the world of long-term investing. With a myriad of options available, it's essential to focus on stocks that offer growth potential and stability.

InvestorPlace 2024 Feb 21
BMY Stock News Image - The Motley Fool

Pfizer and Bristol Myers Squibb have delivered poor financial results of late. Some investors might worry about the future of their dividend programs.

The Motley Fool 2024 Feb 17
BMY Stock News Image - Seeking Alpha

Every month we look at companies that are delivering not only a solid dividend yield but also showing a trend of growing dividends. Companies that can consistently deliver dividend growth due to rising earnings can generate long-term wealth. February 2024's dividend screening article gives us a look at some familiar names but two new names we haven't discussed before.

Seeking Alpha 2024 Feb 17
BMY Stock News Image - Zacks Investment Research

The fourth-quarter results of the healthcare sector have been unimpressive, with earnings of companies that have reported so far down 17.7% despite 7% revenue growth. However, many industry bigwigs reported solid results, with some beating on earnings or revenues or both.

Zacks Investment Research 2024 Feb 12
BMY Stock News Image - Zacks Investment Research

ACLS, BMY and CHX have been added to the Zacks Rank #5 (Strong Sell) List on February 12, 2023.

Zacks Investment Research 2024 Feb 12
BMY Stock News Image - Market Watch

Drugmakers grilled on the cost of prescription drugs on Capitol Hill Thursday sought to deflect the criticism onto drug-market middlemen who they said are pushing list prices for medications higher.

Market Watch 2024 Feb 08
10 of 50